KDA Group Inc. (CVE:KDA) Insider Tenshi Life Sciences Pte. Limited Sells 77,000 Shares

KDA Group Inc. (CVE:KDA) insider Tenshi Life Sciences Pte. Limited sold 77,000 shares of KDA Group stock in a transaction that occurred on Wednesday, September 25th. The stock was sold at an average price of C$0.30, for a total value of C$23,100.00.

Tenshi Life Sciences Pte. Limited also recently made the following trade(s):

• On Monday, September 23rd, Tenshi Life Sciences Pte. Limited sold 43,500 shares of KDA Group stock. The stock was sold at an average price of C$0.30, for a total value of C$13,050.00.
• On Tuesday, September 17th, Tenshi Life Sciences Pte. Limited sold 24,500 shares of KDA Group stock. The shares were sold at an average price of C$0.30, for a total transaction of C$7,350.00.
• On Wednesday, August 28th, Tenshi Life Sciences Pte. Limited sold 160,500 shares of KDA Group stock. The stock was sold at an average price of C$0.30, for a total transaction of C$48,150.00.
• On Monday, July 15th, Tenshi Life Sciences Pte. Limited sold 51,000 shares of KDA Group stock. The shares were sold at an average price of C$0.32, for a total transaction of C$16,105.80.
• On Friday, July 12th, Tenshi Life Sciences Pte. Limited sold 50,500 shares of KDA Group stock. The stock was sold at an average price of C$0.30, for a total transaction of C$15,150.00.
• On Wednesday, July 10th, Tenshi Life Sciences Pte. Limited sold 458,500 shares of KDA Group stock. The shares were sold at an average price of C$0.30, for a total value of C$137,550.00.

KDA Group Price Performance

KDA opened at C$0.28 on Friday. The business has a fifty day moving average of C$0.26 and a 200 day moving average of C$0.34. The stock has a market cap of C$49.11 million, a P/E ratio of -7.50 and a beta of 1.23. The company has a quick ratio of 0.35, a current ratio of 2.10 and a debt-to-equity ratio of 7.36. KDA Group Inc. has a 52-week low of C$0.08 and a 52-week high of C$0.66.

About KDA Group

KDA Group Inc, together with its subsidiaries, provides solutions and services to pharmacies and pharmaceutical companies in Canada. The company operates through three segments: Pharmacy Services, Pharmaceutical Solutions, and Technology. It provides pharmacy staff replacement services, professional and continued medical training services, pharmacy re-engineering services, and pharmaceutical training services.